v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net Income (Loss) $ (663,801) $ (243,833)
Reconciliation of net loss to net cash used in operating activities    
Depreciation and amortization 31,377 29,926
Stock based compensation 76,855 88,165
Issuance of warrants for interest expense 4,303
Changes in operating assets and liabilities    
Accounts payable (62) 12,609
Deferred wages and directors fees -- related party 155,925 124,861
Interest payable - related party (24,000)
Right of use lease 868 1,688
Net cash provided by (used in) operating activities (418,535) 13,416
Cash flows from investing activities    
Purchase of property and equipment (104,630)
Payment of deposit on property (10,000) (50,000)
Additions to patent and trademark costs
Net cash provided by (used in) investing activities (10,000) (154,630)
Cash flows from financing activities    
Proceeds from issuance of common stock and warrants 227,000
Proceeds from the exercise of warrants 125,000
Proceeds from the issuance of notes payable -- RP 20,000 100,000
Net cash provided by financing activities 372,000 100,000
Net increase (decrease) in cash and cash equivalents (56,535) (41,214)
Cash and cash equivalent at beginning of the period 65,200 48,797
Cash and cash equivalent at end of the period 8,665 7,583
Non-cash financing and investing activities    
 Issuance of common stock and warrants on the conversion of notes payable $ 50,000